Revolutionary monitoring at home.
Thilo Schmierer, business development manager for Datwyler, discusses the company's latest medical offering, SoftPulse™, and how its revolutionary materials could bring monitoring home.
2021
Five things to consider for building an Industry 4.0-compatible supply chain.
For their July issue, Pharmaceutical Technology spoke to Rahul Thakar, Technical Key Account Manager at Datwyler, to discuss his vision for a modernized supply chain, including five considerations on Industry 4.0 in the packaging component manufacturing arena.
Smart Goals and Continuous Improvement for a Resilient Sustainability Strategy.
Making every component count toward an environmentally responsible supply chain. By Dirk Borghs, CEO of Datwyler Healthcare Solutions.
Designing parenteral packaging for the sensitivities of large molecule injectables.
Datwyler’s Technical Key Account Manager, Eugene Polini, discusses the industry trend towards biologics and how to design parenteral packaging for these challenging molecules.
Datwyler components increase patient and driver safety.
In an interview with the Swiss online portal moneycab, Datwyler CEO Dirk Lambrecht explains the importance of system-critical components and outlines what Datwyler produces for suppliers of Covid 19 vaccines.
Looking forward to the next generation of parenteral packaging: simplified administration and zero defects.
Yang Congri, Director of Market Development in China for Datwyler's Medical Business, discusses the future of parenteral packaging.
PROTXX and Datwyler Demonstrate Dry-Electrode-Based Neurostimulation.
New technologies enable treatment tailored to each patient’s unique impairment profile.
Quality is king: The case to put quality first in pharmaceutical packaging.
Datwyler’s Technical Key Account Manager, Rahul Thakar, discusses how Datwyler’s highest quality standard, FirstLine™, helps pharmaceutical companies minimize defects.
The process of pharmaceutical elastomer selection for injectable biologics
Datwyler discusses five considerations for selecting parenteral packaging for biologics.
Smart goals and continuous improvement for a resilient sustainability strategy.
Forecasts on the effects of climate change have prompted all industries, including the pharmaceutical sector, to implement more environmentally responsible practices.
Riding the Waves.
Datwyler’s Vice President, Medical, Stefan Sevens, discusses five considerations for electrode design to maximize performance, comfort, and durability of wearables.
Datwyler contributes to Covid 19 vaccines.
Datwyler is able to make an important contribution to the global fight against the pandemic with its system-critical elastomer components. The company is supporting the leading pharmaceutical companies in the provision of COVID-19 vaccines.
Electrode Design for Wearables: Points to Consider.
Stefan Sevens, VP Medical at Datwyler, talks about maximizing performance, comfort, and durability of wearable devices.
Datwyler with strong demand in Healthcare Solutions and Food & Beverage units.
In an interview with the Swiss online portal «The Market», Datwyler CEO Dirk Lambrecht explains the potential of Healthcare Solutions and Food & Beverage, and explains why e-cars are not a disadvantage for Datwyler.
Building a better profiled syringe for COVID-19 vaccine packaging.
Datwyler's Global Platform Leader for Prefilled Syringes and Cartridges, Carina van Eester, shares key learnings since the launch of Datwyler's NeoFlex™ plungers at the start of the COVID-19 pandemic.
Covid vaccines, world herd immunity only in three years.
Datwyler’s Global Head of Marketing and Product Management, Massimo Mainetti, discusses how packaging suppliers are helping to reach global herd immunity in 3 years.
Drug Defense: Designing Against Defects.
In times of crisis—like the current COVID-19 pandemic—there is no time or resource to waste on the issues that stem from defective or problematic drug packaging. Datwyler’s Key Account Manager, Rahul Thakar, explains how quality-by-design thinking enables drug efficacy and minimized opportunities for contamination.
Looking forward to the next generation of macromolecular injection packaging: simplified administration and zero pollution.
Datwyler’s Senior Vice President, Pharma, Glenn Thorpe, discusses the future of parenteral packaging.
Looking forward to the next generation of macromolecular injection packaging: simplified administration and zero pollution.
Datwyler’s Senior Vice President, Pharma, Glenn Thorpe, looks to the next-generation of parenteral packaging and how the latest innovations improve patient safety.
2020
Drug defence: designing against defects.
«Quality by Design» thinking enables drug efficacy and minimises opportunities for contamination.
Designing against defects.
Datwyler’s Technical Key Account Manager, Rahul Thakar, discusses how ‘Quality-by-design’ enables drug efficacy & minimises contamination.
Preserving the Parenterals of Tomorrow: How the Right Components, and Their Manufacturing Setup, Can Meet the Needs of an Evolving Market.
Datwyler’s Senior Vice President of Pharma, Glenn Thorpe, discusses the evolution of the parenteral drug market and how parenteral packaging is meeting these ever-changing challenges.
Securing the supply.
Navigating pharma’s packaging challenges amid a pandemic.
The Process of Pharmaceutical Elastomer Selection for Injectable Biologics.
Datwyler discusses five considerations for drug manufacturers to consider when selecting parenteral packaging for their drug products.
Preserving the Parenterals of Tomorrow: How the Right Components, and Their Manufacturing Setup, Can Meet the Needs of an Evolving Market.
Datwyler’s Senior Vice President of Pharma, Glenn Thorpe, discusses the evolution of the parenteral drug market and how parenteral packaging is meeting these ever-changing challenges.
Preserving the parenterals of tomorrow.
Glenn Thorpe, Senior Vice President, Pharma at Datwyler, says pharmaceutical companies should engage with packaging suppliers that can meet the industry demands of the pandemic.
Drug Protection: Eliminate Defects.
In OFWeek, Datwyler discusses how to set goals for zero defects in pharmaceutical packaging manufacturing and why this is a critical process consideration, especially during a pandemic.
The Next Generation of Coated Plungers from Datwyler.
In Korean publication, Plastic Net, Datwyler’s Global Product Leader for Prefilled Syringes and Cartridges, Carina van Eester, discusses the features and benefits of Datwyler’s NeoFlex™ plungers.
Smart goals and continuos improvement for a resilient sustainability strategy.
Dirk Borghs considers the obligation of the pharmaceutical sector to implement environmentally responsible practices, and discusses the steps Datwyler is taking in its efforts for sustainability.
The Next Generation of Coated Plungers from Datwyler.
In Korean Packaging Association, Datwyler’s Global Product Leader for Prefilled Syringes and Cartridges, Carina van Eester, discusses the features and benefits of Datwyler’s NeoFlex™ plungers.
Injection Devices: Will COVID-19 Deliver Growth to the Market?
In May, Project Jumpstart, a public-private initiative, was announced that will pump $138 million into the production of 100 million prefilled syringes by the end of this year and another 500 million in 2021, should a COVID-19 vaccine become available. Yet, industry gurus do not necessarily agree that the pandemic will have a positive impact on the injection delivery market. Datwyler’s Global Platform Leader for Prefilled Syringes and Cartridges, Carina van Eester, discusses the important role that coated plungers play in ensuring the appropriate functionality and compatibility of injection devices.
Achieving Zero Defects in a Pandemic.
When Lives and Livelihoods Depend on Accelerating Large Molecule Drug Production, Biopharma Companies must Minimize Defects and Contamination» says Massimo Mainetti, Global Head of Marketing and Product Management, Datwyler.
«Aiming for Perfection in a Pandemic», an opinion by Datwyler.
«When Lives and Livelihoods Depend on Accelerating Large Molecule Drug Production, Biopharma Companies must Minimize Defects and Contamination» says Massimo Mainetti, Global Head of Marketing and Product Management, Datwyler.
The next generation of coated plungers.
Carina Van Eester explores the benefits of fully coated plungers for prefilled syringes and cartridges.
Prefilled Syringes & Parenteral Manufacturing: Innovations, Challenges & Solutions.
Plunger Designed with Functionality in Mind.
Innovating Drug Delivery to Carry Us to the ‘New Normal’.
The growth of injectables, personalized medicine, anti-counterfeiting measures, and automation are a few trends that may follow the industry into a new normal.
How the drug delivery systems market is changing.
Rahul Thakar, PhD, technical key account manager at Datwyler Pharma, discusses the rise of injectables, quality control measures, and personalization.
Datwyler launches spray-coated plungers to minimise leachables.
Datwyler has launched its NeoFlex plungers to help developers better protect the integrity of injectable formulations and optimise the functionality of prefilled syringes and cartridge.
2019
Ensuring Container Closure Integrity through a Parenteral Packaging System Approach.
Container closure integrity (CCI) is an increasingly relevant issue in the pharmaceutical packaging industry. It addresses the maintenance of integrity to prevent microbial ingress in sterile product packaging until the time of use, as well as to restrict the loss of product contents and to prevent the entry of detrimental gases or other materials.
Elastomer manufacturing: primary packaging for parenteral drugs.
With the advent of biologics and highly sensitive drugs, primary packaging materials must meet the highest-level of functional, regulatory and cleanliness standards to ensure compatibility and ultimately, patient safety. Rahul Thakar, PhD, discusses Datwyler's solution to these ever-stricter requirements is their highest-quality manufacturing standard, FristLine™.